Skip to main content
. Author manuscript; available in PMC: 2021 Jun 2.
Published in final edited form as: Ann Allergy Asthma Immunol. 2020 May;124(5):424–440.e17. doi: 10.1016/j.anai.2020.03.021

Table 4.

Summary of Findings for PICO Question 4a

Elemental diets compared to placebo for the management of EoE
Outcomes and follow-up No. of participants (studies)5661 Certainty of the evidence (GRADE) Relative effect, RR (95% CI) Anticipated absolute effects
Risk with placebo Risk difference with elemental diets
Not achieving histologic remission (eos <15/hpf) follow-up: mean 8 wk 431 (6 observational studies)b,c,d ⊕⊕⊕◯ MODERATEe 0.07 (0.05–0.12) 880 per 1000 807 fewer per 1000 (824 fewer to 763 fewer)
a

The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

b

Five subjects excluded for noncompliance to diet; 2 subjects excluded for not getting follow-up endoscopy (Kelly et al56).

c

Eight subjects excluded for noncompliance (Licarous et al57).

d

Histologic remission defined as <10 eos/hpf; 11 who started diet dropped out (Peterson et al59).

e

Upgraded for very large effect size.